Michelon Francois Roger 4
4 · ENDRA Life Sciences Inc. · Filed Apr 7, 2021
Insider Transaction Report
Form 4
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2021-04-05+50,000→ 50,000 totalExercise: $2.64Exp: 2031-04-05→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022.